Home/Nanoligent/Dr. R. Mangues
DR

Dr. R. Mangues

Co-Founder

Nanoligent

Therapeutic Areas

Nanoligent Pipeline

DrugIndicationPhase
CXCR4-Targeted TherapyOncology (Tumor Growth & Metastasis)Preclinical